Research guide for for athletes — mechanisms, protocols, and independent analysis from Compound Review.
Why TB-500 Works for Athletic Recovery
TB-500 is a synthetic analogue of Thymosin Beta-4 (Tβ4), specifically the actin-binding domain fragment Ac-LKKTETQ. In athletic contexts, its primary applications are injury prevention and accelerated recovery — tendon, ligament, and muscle repair. TB-500 promotes actin polymerization, upregulates cell migration factors, and reduces inflammatory cytokines at injury sites. It is often used by athletes with high injury frequency or during post-surgical recovery.
TB-500 Dosage Protocol for Athletes
Athletic research protocols use TB-500 at 2–2.5 mg subcutaneously twice weekly for 4–6 weeks (loading phase), followed by 2–2.5 mg once every 2 weeks (maintenance). Injection near the injury site is preferred for localized tissue repair; systemic subcutaneous injection is used for full-body recovery protocols. TB-500 is often stacked with BPC-157 for synergistic connective tissue repair.
TB-500 vs BPC-157: Which Should Athletes Use?
TB-500's evidence base is primarily preclinical — animal studies demonstrate accelerated wound healing, cardiac repair, and tendon recovery. No completed human RCTs exist. The compound is not FDA-approved and is classified as a research chemical. It is prohibited under WADA anti-doping regulations. Athletes should note that TB-500 is detectable in urine and blood samples.